Founded in San Diego, CA in 2009 by Mario A. Bourdon BioLaurus is an In Vivo Preclinical Molecular Imaging specialist combining study design consulting, study management, and image analytics. We are a solutions focused company working collaboratively with you to address the complex research challenges you face in drug discovery and translational research. From discovery stage efficacy studies to follow-on safety studies for clinical stage drugs we have a demonstrated ability to develop innovative studies and in vivo assays harnessing the power of in vivo quantitative imaging.
From the perspective of 30+ years in oncology and cell biology research Mario recognized that a new technology was emerging on the preclinical research scene, molecular imaging, that would be transformative. Here was a new set of technologies that could “see” into the living animal and collect quantitative data and do it longitudinally. Molecular imaging was imagined as the “tricorder” of drug discovery and drug development research. To a significant degree that promise has been born out in the studies we have been privileged to work on for our clients.
As BioLaurus worked with our big pharma clients it became clear that innovation and adaptability would be key in maximizing value. As a result we have become leaders in assay development in both rodents and NHP with particular emphasis on platelet PK and sequestration analysis, and CNS PET Receptor Occupancy PK analysis.